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Introduction. The Medical Outcome Study Short Form 36 (SF-36) is widely used for measuring Health-Related Quality of Life
(HRQoL) and has undergone rigorous psychometric evaluation using Classic TestTheory (CTT). However, Item ResponseTheory-
based evaluation of the SF-36 has been limited with an overwhelming focus on individual scales and cross-sectional data. Purpose.
This study aimed to examine the longitudinal item and category stability of the SF-36 using Rasch analysis. Method. Using data
from the 1921-1926 cohort of the Australian Longitudinal Study on Women’s Health, responses of the SF-36 from six waves of data
collection were analysed. Rasch analysis using Winsteps version 3.92.0 was performed on all 36 items of the SF-36 and items that
constitute the physical health and mental health scales. Results. Rasch analysis revealed issues with the SF-36 not detected using
classical methods. Redundancy was seen for items on the total measure and both scales across all waves of data. Person separation
indexes indicate that the measure lacks sensitivity to discriminate between high and low performances in this sample.The presence
ofDifferential ItemFunctioning suggests that responses to itemswere influenced by locality andmarital status.Conclusion. Previous
evaluations of the SF-36 have relied on cross-sectional data; however, the findings of the current study demonstrate the longitudinal
efficacy of the measure. Application of the Rasch Measurement Model indicated issues with internal consistency, generalisability,
and sensitivity when the measure was evaluated as a whole and as both physical and mental health summary scales. Implications
for future research are discussed.
1. Introduction
To be deemed effective and useful, health measures must
fulfil several requirements including validity, reliability, inter-
pretability, and responsiveness to change [1]. Measurement
invariance is another important characteristic, ensuring that
the same construct is being consistently measured across
different populations and settings, and over time. Consider-
ations of measurement invariance are important for longitu-
dinal studies that seek to gauge change in a construct, across
a broad population and over time. When studies involve
an older population, measurements may be vulnerable to
instability as the participants age, their living circumstances
may change, and their physical and cognitive abilities may
decline [2, 3].
TheMedical Outcome Study Short Form 36 (SF-36) is one
of the most commonly used questionnaires for monitoring
Health-RelatedQuality of Life (HRQoL) across amultitude of
populations and settings, including client groups and healthy
populations [4–10]. HRQoL refers to aspects of quality of
life that are impacted by an individual’s mental and physical
health [11].
Development of the SF-36 came about following difficul-
ties during the Health Insurance Experiment (HIE), whereby
the completion of a lengthy health survey was refused by
participants [9]. In response to this need, Ware et al. [9]
constructed a health survey that was both comprehensive
and relatively short. The initial survey, the SF-18, comprised
of 18 items measuring physical functioning, role limitations
relating to poor health, mental health and health perceptions
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[9]. Subsequently, additional items have been added to create
the 20-item SF-20 version, and 36-item SF-36 version which
is now the most commonly used.
TheSF-36measures eight key health concepts: (1) physical
functioning (PF); (2) role limitations due to physical health
problems (RL-P); (3) bodily pain (BP); (4) general health
(GH); (5) vitality (V); (6) social functioning (SF); (7) role
limitations due to emotional problems (RL-E); and (8)
mental health (MH) [9]. From the eight scales, the survey
generates overall physical and mental health component
summary scores. Both summary measures include scores
from all eight subscales; however particular correlations are
present; the physical functioning, role limitations-physical,
and bodily pain scales should correlate highest with the
physical component score (PCS) and lowest with the men-
tal component score (MCS) [12]. The mental health, role
limitations-emotional, and social functioning scales should
correlate highest with theMCS and lowest with PCS, with the
remaining general health and vitality scales found to correlate
moderately with both the PCS and MCS [12]. Summary
score results can be compared with gender and age-group
norms derived from the general population, e.g., United
States population norms [12].
The SF-36 is now widely used for both research and
clinical purposes and has undergone rigorous psychometric
evaluation nationally and internationally using Classic Test
Theory (CTT) [6, 7, 9, 10]. CTT seeks to determine the
reliability of a whole instrument through evaluating the
degree of variance in terms of the ratio between true and
observed scores. Therefore observed results are the product
of the respondent’s “true score,” in combination with error
[13].
A relatively new approach to psychometric test design
is Item Response Theory (IRT; Edelen and Reeve) [14].
IRT models are typically considered to be unidimensional,
assessing instrument reliability at item-level rather than
instrument-level, by determining the unique contribution
of each item to the construct or trait being measured. IRT
considers the importance of participants’ responses, whereby
the probability of their answering a particular item correctly
is based on their responses to other items of greater or
lesser levels of difficulty or challenge [14]. Within IRT, the
Rasch Measurement Model (RMM) is the most frequently
applied IRT approach to investigating the unidimensionality
of items that make up scales and to determining if responses
are indeed measuring a single dimension only, through the
examination of item fit statistics [15].
1.1. Application of IRT/RMMto the SF-36. Under the assump-
tions of an IRT model, instruments deemed reliable should
meet the following properties: unidimensionality, hierarchi-
cal ordering of items, and reproducibility of scale items
across client populations [16]. Unidimensionality assumes
that a collection of items represent and assess a single
construct, that is, fit a single one dimensional model [16].
Item hierarchy refers to a hypothesised continuum along
which instrument items should progress in difficulty from
easier to more challenging to answer. In other words, the
probability of answering the more difficult items is higher
for those individuals with higher levels of the latent trait
being measured, while those with lower levels of the trait
have a lower probability of answering items at the upper
end [16]. Reproducibility relates to item hierarchy whereby
item order and calibrations along the continuum are seen to
remain relatively stable or constant across different groups
of assessment respondents and assessment occasions [16].
Item reproducibility or stability is considered essential to the
ability to accurately measure between-group differences and
within-group changes over time [16].
IRT-based evaluation of the SF-36 has overwhelm-
ingly focused on individual scales, particularly the Physical
Functioning-10 subscale, with only some studies having
examined particular psychometric properties of the SF-36
as a whole instrument or by component summary scores
[5, 6, 12, 16, 17].
1.2. Unidimensionality and Item Fit. Only a few analyses have
investigated the model-fit of the SF-36 as a whole. A prospec-
tive cohort study, involving a sample of 583 participants who
were opioid-dependent, assessed item-model fit and latent
trait factors for the eight SF-36 subscales and for the whole
instrument [6].The RMM reliability estimates of all eight SF-
36 subscales (including a revised PF-10 subscale) established
that each measured a single latent trait [6]. Investigation
of the dimensional structure of the instrument as a whole
confirmed the presence of an eight-factor model; that is, the
SF-36 measured eight distinct latent traits [6].
Analysis confirming a two-factor structure, reflecting
the SF-36 physical and mental health components, has also
been conducted using principal component analysis, with
the physical and mental health domains accounting for 70%
of the total variance across both standard and acute forms
[12]. A single-administration survey with a general U.S.A.
population sample (n = 634) evaluated the item-fit of the SF-
36 physical and mental HRQoL domains using RMM mod-
elling [5]. In this analysis, eight items in the physical domain
had disordered thresholds, whereby a person responding to
higher or lower levels of a categorical scale did not necessarily
possess higher or lower levels of the trait that was being
assessed [5]. The authors suggested collapsing some category
options to overcome this issue [5]. In terms of the HRQoL
domains’ unidimensionality, the mental health items were
seen to fit RMM expectations, whereas the physical domain
required discarding of the seven misfitting items to produce
a 14-item domain that met RMM requirements. Survey data
for of 395 Taiwanese patients with chronic lung disease were
analysed to conduct similar assessments of the SF-36 mental
and physical health domains, with the authors concluding
that each domain was unidimensional [7].
Differential item functioning (DIF) analysis using IRT-
based techniques has also been undertaken with the SF-
36. DIF refers to the unequal endorsement of instrument
items by respondents of different groups, given that the items
intend to measure the same latent trait [10]. The presence
of DIF undermines instrument construct validity and may
compromise the ability to compare instrument scores across
different groups of respondents [10]. Yu et al. [10] utilised the
multiple-indicator, multiple-causes (MIMIC) technique, and
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an IRT-based methodology to detect if DIF existed in the SF-
36 physical and mental health domains. Data were extracted
from the 1994-95 cohort of the Southern California Kaiser
Permanente database (n = 7,538), which evaluated the health
outcomes of patients receiving pharmacist consultations.
DIF across SF-36 physical and mental health domains was
analysed in relation to the presence of five key disease types:
hypertension, rheumatic conditions, respiratory diseases,
depression, and diabetes. Results indicated the presence of
statistically significant DIF for a total of five items, both
physical and mental health-based, for the hypertension, res-
piratory, and diabetes groups, respectively [10]. The authors
concluded that the presence of DIF for only five of 36 items
did not warrant significant concern regarding the overall
construct validity of the SF-36; however, they cautioned
regarding the use of the SF-36 in comparing groups based on
hypertension in particular, who returned DIF effect for two
items in the physical health domain [10].
1.3. Cross Cultural Item Response Patterns. Rasch modelling
has also been applied to translated versions of the SF-36 to
examine its cross-cultural validation. An assessment of the
appropriateness of a Korean version of the SF-36 with 510
elderly Korean adults was conducted using the RMM [17].
The authors verified the presence of unidimensionality in the
instrument and determined through step calibration that the
response options of three- and five-point scales for itemswere
appropriate for this population [17]. Goodness-of-fit statistics
however determined that nine items across the instrument
were not appropriate for this population, in terms of being
incongruent with other items, having significant overlap with
other items, or creating confusion due tomisinterpretation of
the meaning of items [17].
1.4. Item Stability. While item-model fit and determination of
the presence of DIF are important, these properties can mean
very little if item responses are inconsistent or changeable
over time. Evaluation of the stability of item responses is
important to determining the rigour of an instrument. Most
IRT evaluations of SF-36 data have been cross-sectional and
therefore stability of item response has not been evaluated [5–
7, 10, 17]. Two studies assessed performance across repeated
administrations, following pre-post designs [18, 19]. Martin
et al. [18] utilised the SF-36 as one of three evaluation tools
pre- and posttreatments for rheumatoid arthritis (n = 339),
but with the aim to compare measurement properties of these
tools and determine sensitivity to change rather than stability.
IRT analysis of the PF-10 revealed weaknesses in sensitivity
to treatment response at 6 and 12 months, with authors
suggesting construction of a more comprehensive measure.
McHorney et al. [19] compared IRT and Likert scoring
method of the SF-36 Physical Functioing-10 scale, using a
pre-post design. The findings showed apparent differences
in patients with very high and low physical functioning,
suggesting that Rasch model of scoring may have impor-
tant implications for clinical interpretations of the scale
[19].
Only one longitudinal study has evaluated properties of
the SF-36 using IRT methodologies. The first administration
of the standardised SF-36 was conducted as part of a four-
year longitudinal Medical Outcomes Study of patients (N =
3,445) with chronic medical and psychiatric conditions [16].
Examination of the reproducibility of the item calibrations
of the Physical Functioning-10 scale was conducted, from
baseline to two years [16]. A high degree of consistency in
item calibration between the two time points was found,
both in order and magnitude [16]. However, this longitudinal
study only evaluated the stability and structural validity of
the Physical Functioing-10 scale using IRT. The stability of
the remaining SF-36 subscales, the physical andmental health
domains, and the measure as a whole over time has not been
examined using IRT to date.
A lack of evaluation regarding the performance of the SF-
36 over time presents a significant gap in the literature, with
unanswered questions about its measurement stability. It is
vital that the long-term reliability of the SF-36 is examined,
to determine its true suitability for inclusion in large-scale
longitudinal studies tracking participants, particularly as they
age over extended periods of time. This study therefore
seeks to use an IRT-based methodology to evaluate the item
stability of the SF-36 total and component summaries in a
large, longitudinal data set. The following questions guided
this research:
(1) Is there disordering or dysfunction within the SF-36
items against the construct being measured?
(2) Do the SF-36 items have a consistent hierarchy of
difficulty and good distribution across all waves of a
longitudinal survey?
(3) Is the SF-36 differentiating discreet subgroups of
people reliably (e.g., urban vs. regional)?
(4) Does the SF-36 measure one or more constructs?
(5) Were all items in the SF-36 instrument used by all
participant subgroups in the same way?
2. Methods
Data were from an Australian prospective, population-based
survey. The Australian Longitudinal Study on Women’s
Health (ALSWH) aims to assess physical and emotional
health, use of health services, health risk factors and
behaviours, life stages, and demographic characteristics. The
ALSWH is conducted by researchers from the University of
Newcastle and the University of Queensland and is funded by
the Australian Government Department of Health.The study
commenced in 1996 and has been running for over 20 years.
2.1. Participants. Three cohorts of women born in 1973-78
(aged 18-23 in 1996), 1946-51 (aged 45-50), and 1921-26 (aged
70-75) were randomly selected from the Medicare database,
which includes all Australian citizens and permanent res-
idents. Women living in regional and remote areas were
sampled at twice the rate of women living in urban areas in
order to allow formeaningful statistical comparisons between
urban and country-dwelling women.
Over 40,000 respondents initially responded to the base-
line postal survey in 1996 with response rates across the three
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age groups ranging between 37% and 52% [20]. Although
some immigrant groups were underrepresented and tertiary
educated women were overrepresented, the responding sam-
ples were considered to be “reasonably representative” of the
Australian female adult population following a comparison to
census data [21]. Each cohort has since been surveyed every
three years on a rolling basis, commencing with the 1946-
51 cohort in 2018, the 1921-26 cohort in 1999, and the 1973-
78 cohort in 2000. Only data from the 12,432 respondents
in the 1921-26 cohort were analysed in the current study. At
the commencement of the longitudinal survey, these women
were aged 70-75 years, and at the time of survey six, they were
aged in their early nineties (N = 4,055), with most attrition
being due to death (N = 5,273).
A study analysed potential biases introduced through
the attrition of participants from this cohort between survey
one and survey five [22]. Nondeath attrition was related to
having less education, not being born in Australia, being
a current smoker, and having poorer health in this cohort.
Analysis comparing the survey population to the Australian
Census data collected over the same time period showed
an increase in the underrepresentation of women from
non-English speaking backgrounds and an increase in the
overrepresentation of current and ex-smokers. Differences
between the study population and the national population
were considered to have changed “only slightly” between
survey one and survey five.
2.2. Instrument. The SF-36 HRQoL scale is included in each
survey. At baseline in 1996, mean scores for the 1921-26
cohort were lower than for other cohorts for the physical
health subscales (PF, RP, and BP) and higher than for other
cohorts for the mental health subscales (MH, RE, and BP)
[23]. Over time, mean PF scores scale have declined, but with
significant variation across different subgroups within the
cohort [24]. Mean MH scores have remained relatively stable
[25].
2.3. Data Analysis. A two-stepped approach was taken to
evaluate the reliability and validity of the SF-36. Across
surveys one to six. First, Rasch analyses using Winsteps
version 3.92.0 [26], with the joint maximum likelihood
estimation method [27] were performed on all 36 items for
each of the six waves of data collection and then on the items
that constitute the physical health scales (PF 10-items, RP
4 items, BP 2 items, and GH 5 items), the mental health
scales (V, SF 2 items, RE 3 items, and MH 5 items) and the
item measuring health transition for each wave of data. The
RMM was adopted for the data analysis since the 6-point
response Likert scale was invariant across all the 36 items.
The RMM adopts a “the data fit the model” approach. “The
empirical data must meet the prior requirements of Rasch
model in order to achieve objective measurement” [28, p.
65]. Several criteria including item infit and outfit statistics,
reliability measures, rating scale functioning, and differential
item functioning (DIF) were used to investigate the quality of
the SF-36 total scale, physical health scale, and mental health
scale. Item fit statistics indicate the extent to which the data
match the expectations of the RMM. Outfit and Infit mean
square (MNSQ) as well as their standardized forms (ZSTD)
are used.
2.3.1. Is There Disordering or Dysfunction within the SF-36
Items against the Construct Being Measured? Response Scale.
Category and step (threshold) disordering of the response
scale was examined. To determine whether the rating
response scales were being used in the expected manner, the
rate at which average measure scores (frequency endorsed)
increased in relation to category increases was examined
for even distribution. A uniform category distribution is
achieved when average measure scores increase monotoni-
cally as the category increases. If categories are poorly defined
or items are included that do not fit the construct, then
non-uniformity occurs. Fit mean squares (MNSQ) below 0.7
or above 1.4 indicate a category misfit. When disordered
categories are measured then a consideration should bemade
to collapse it with an adjacent category [29].
The distance between categories is indicated by Andrich
thresholds, or step calibrations. If there is no overlap, then
categories should progress monotonically. Disordered steps
indicate that the category defines only a narrow definition of
the variable, rather than a problem with the sequencing of
category definitions. An increase of at least 1.0 logit indicates
distinct average measure categories on a 5-category scale, and
gaps in the variable are indicated by an increase of >0.5 logits
[30].
2.3.2. Do the SF-36 Items Have a Consistent Hierarchy and
Good Distribution across All Waves? Person and Item Fit
Statistics. Misfitting items and the pattern of responses for
each survey respondent were identified using fit statistics.
These are used to determine whether an instrument is a valid
measure of the construct it claims to measure. Fit statistics,
reported as log odd units (logits), will be examined to
determine whether the items contribute to the measurement
a single construct, and the reliability of any one person’s
responses. The item constructs reviewed in this study are
health related quality of life as a whole, as well as quality
of life related to physical health and mental health. Two
unstandardized statistics, MNSQ and Z-Standard (Z-STD),
were used tomeasure item and person infit and outfit. MNSQ
values for infit and outfit should have a value close to 1.0 to fit
the model for rating scales, but values within the range of 0.7-
1.4 are considered acceptable [15]. The model is degraded by
underfit (i.e., values > 1.0), indicating the possibility for other
sources of variance in the model and further investigation is
required to determine the reason for the underfit. Conversely,
overfit (values < 1.0) does not always degrade the model and
could result in a misinterpretation that the model worked
better than expected [15]. Z-STDvalues for outfit are expected
to reach 0. If a value exceeds ±2, it is deemed to fall outside of
the predicted model [15].
The person reliability statistic is equivalent to Cronbach’s
alpha used in CTT and indicates a measure’s internal con-
sistency (the relatedness amongst items) [15]. When person
reliability values are low (i.e., < 0.8), the implications are
twofold: (1) an instrument may not be sensitive enough to
distinguish between high and low performers andmore items
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are required; or (2) there were not enough persons in the
sample with both high and low extreme values (a narrow
range of person measures).
Person separation (if the outlying measures are acci-
dental) and person separation index (PSI)/strata (if the
outlying measures represent true performances; 4∗person
separation +1/3) are used to classify people. Person separation
reports whether the test separates the sample into enough
levels with reliability of 0.5 separating into only one or two
levels. Low person separation suggests that the instrument is
not sensitive enough to separate high and low performers,
0.8 indicating separation into 2-3 levels and 0.9 indicating
separation into 3 or 4 levels [29]. PSI/strata of 3 are needed
to consistently identify three different levels of performance
(i.e., the minimum level required to attain a reliability of 0.9).
Item reliability verifies item hierarchy with <3 levels (high,
medium, and low) with item reliability < 0.9 indicating the
sample is too small to confirm the construct validity (item
difficulty) of the instrument.
2.3.3. Does the SF-36 Measure One or More Constructs?
Dimensionality of the Scale. Dimensionality is tested by
the following: (a) finding potentially problematic items by
checking negative point-biserial correlations; (b) identifying
misfitting persons or items using Rasch fit statistics; and (c)
conducting Rasch factor analysis using principal components
analysis (PCA) of the standardised residuals [31]. PCA of
residuals checks that there are no further principal compo-
nents (dimensions) after the intended or Rasch dimension
is removed. No further dimensions are indicated if the
residuals for pairs of items are uncorrelated and normally
distributed. The criteria for determining the presences of
further dimensions in the residuals were as follows: (1) >60%
of the variance is explained by the Rasch factor; (2) an
eigenvalue of <3 on first contrast; and (3) variance explained
by the first contrast is <10% [32].
The person-item dimensionality map provides a
schematic representation of how person abilities and item
difficulties are distributed using a logit scale. Items that
represent similar difficulty will occupy the same place on the
logit scale. If a person is represented on the logit scale with no
corresponding item, then there are gaps in the item difficulty
continuum. Another indicator of overall distribution is the
person measure score. If people in the sample are more
able than the most difficult item on a scale, then the person
measure score location will be lower than the centralised
item mean measure score (i.e., <50). If people in the samples
are less able than the items on a scale, then the mean person
location will be higher (i.e. >50).
2.3.4. Were All Items in the SF-36 Instrument Used by All
Groups in the Same Way? Differential Item Analysis. A dif-
ferential item analysis (DIF) was performed to investigate
whether items in the instrument were used by all groups
in the same way. DIF is noticeable when a response to
an item is influenced by a characteristic of the respondent
other than their ability on the underlying trait. For DIF
analysis, the sample was categorised by marital status (single,
widowed, divorced,married, de facto, and other) and location
(urban vs. regional). In determining DIF when comparing
two groups (i.e., urban and regional) the hypothesis “this item
has the same difficulty for two groups” is used.The difference
in the difficulty of the item between the two groups, indicated
by the DIF contrast, should be at least 0.5 logits with a p-
value < 0.05 for DIF to be noticeable. In determining DIF
when comparing more than two groups (i.e., marital status)
the hypothesis “this itemhas no overall DIF across all groups”
is used. DIF is then determined using the chi-square statistic
and p-value < 0.05 [29].
3. Results
SF-36 data were gathered over six waves: Wave 1, N = 12,077;
Wave 2, N = 10,411; Wave 3, N = 8,577; Wave 4, N = 7,112,
Wave 5, N = 5,534; and Wave 6, N = 4,032. The sample size
decreased with each subsequent phase of data collection as
participants died or were lost to follow-up.
3.1. SF36 Total Scale Rasch Analysis for Six Waves of Data
Collection. Total Rasch scale item statistics for six waves of
data collection are shown in Table 1. When all 36 SF-36 items
were calibrated using the RMM for the six waves of data
collection, MNSQ infit statistics ranged from 0.13 to 2.43 and
outfit statistics ranging from 0.22 to 2.64 (see Table 2). The
mean item measure was 0.00 logits (SD = 1.12). With respect
to logit measures, there was a broad range, the lowest value
being –3.01 and the highest value being +2.31.This resulted in
an average item separation index of 77.98 and an average item
reliability of 1.00 over the six waves (see Table 3).
The SF-36 total scale person-item map in Supplemental
Figure 1 shows evidence of consistent hierarchical ordering
of the SF-36 total scale items. Items which were less difficult
are located at the bottom of the person-itemmap while more
difficult items are located at the top of the map. The figure
also shows that while each of the waves had a reasonable
distribution of items in relation to item difficulty, several of
the SF-36 total scale items have the same level of difficulty.
Rasch analysis reports the calibrations of the five thresh-
olds (for the six-category rating scale) increasemonotonically
from -3.15, -1.36, -.25, .48, 1.31, and 2.82 for wave one and -
2.96, -1.30, -.31, .42, 1.29, and 2.78 for wave six.
The average person measure was 0.75 logits (SD = 0.23)
over the six waves of data collection (see Table 3). The mean
person separation was 0.73 with a mean reliability of 0.35
(see Table 3). When examining the overall RMM output of
the SF-36 total scale, the average personmeasure (0.75 logits)
was higher than the average item measure (0.00 logits). The
range of logit values for items was from +1 to -3 logits. The
person reliability was 0.35 and item reliability was 1.00. This
places the item reliability for the SF-36 total scale in the
acceptable range and the person reliability correlation in the
unacceptable range.
The separation index for items was greater than 2.0 indi-
cating adequate separation of the items on the construct being
measured. However, the separation index for persons was less
than 2.0 indicating inadequate separation of participants on
the construct.
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Table 3: SF-36 total scale Rasch analysis summary Item and Person Infit and Outfit statistics for six waves of data collection.
Wave 1 Wave 2 Wave 3 Wave 4 Wave 5 Wave 6
Persons Mean -.69 -.68 -.72 -.75 -.80 -.85
S.D. .24 .22 .24 .23 .23 .24
MAX .82 .29 .64 .67 .03 .15
MIN -4.33 -2.70 -2.60 -2.59 -2.54 -2.76
Infit-MNSQ 1.03 1.02 1.03 1.04 1.04 1.03
Infit-ZSTD -.30 -.40 -.30 -.20 -.20 -.10
Outfit-MNSQ 1.01 1.01 1.00 1.00 .99 .99
Outfit-ZSTD -.40 -.40 -.30 -.30 -.30 -.20
Person separation .81c .60c .72c .71c .75c .78c
Person reliability .40a .26a .34a .33a .36a .38a
Items Mean .00 .00 .00 .00 .00 .00
S.D. 1.11 1.19 1.20 1.21 1.22 1.26
MAX 1.94 1.96 2.05 2.08 2.09 2.31
MIN -2.64 -2.92 -2.98 -3.01 -2.86 -2.89
Infit-MNSQ .98 .99 .98 .98 .98 .99
Infit-ZSTD -2.30 -2.30 -2.20 -1.90 -1.40 -.90
Outfit-MNSQ .99 1.00 .98 .98 .98 .98
Outfit-ZSTD -2.30 -2.30 -2.30 -2.00 -1.50 -1.10
Item separation 93.40 89.72 82.81 76.45 67.43 58.09
Item reliability 1.00 1.00 1.00 1.00 1.00 1.00
Notes. aPerson or item reliability <0.8; bItem separation <3.0; cPerson separation <2.0; values in italic for Infit or Outfit MnSq > 1.34; values underlined for
Infit or Outfit MnSq < 0.64.
Item fit to the unidimensionality requirement of the
RMM was also examined. Eleven out of the 36 items were
found to have MNSQ infit and outfit statistics inside the
0.70 to 1.30 range and/or a z-score that fell inside the
+2 to -2 range. Specifically, items CH01:Q1, PF01:Q3A,
PF04:Q3D, PF06:Q3F, PF07:Q3G, MH04:Q9F, VT03:Q9G,
VT04:Q9I, SF02:Q10, CH02:Q11A, and GH04:Q11C met
the RMM requirements (see Table 2). In other words, only
30.6% (i.e., 11 of 36) of the 36 SF-36 total scale items met
the RMM requirements. The following items had an Infit
MnSq statistic that was less than 0.70: HT:Q2, PF02:Q3B,
PF03:Q3C, PF05:Q3E, PF08:Q3H, PF09:Q3I, PF10:Q3J,
RP01:Q4A, RP02:Q4B, RP03:Q4C, RP04:Q4D, RE01:Q5A,
RE02:Q5B, and RE03:Q5C. The following items had an Infit
MNSQ statistic that was greater than 1.30: FO01:Q6, BP01:Q7,
BP02:Q8, VT01:Q9A, MH01:Q9B, MH02:Q9C, MH03:Q9D,
VT02:Q9E, MH05:Q9H, GH02:Q11B, and GH05:Q11D.
The Winsteps RMM program determines the dimen-
sionality of a scale by using a Rasch-residual principal
components analysis. When the item residuals from the
RMM output were factor analysed, no significant factor
loadings were present (see Table 4). This indicated that the
unidimensional requirement of the SF-36 total scale was
met. The raw variance explained by the SF-36 total scale
over the six waves of data collection ranged from 58.5%
to 62.1% and the unexplained variance in the first contrast
ranged from 11.9% to 14.5%. The residual analysis completed
indicated that no second dimension or factor existed. Linacre
[32] suggests that a first single factor with 60% or greater
of the accounted for variance is considered a reasonable
unidimensional construct. “A second factor or residual factor
should not indicate a substantial amount of variance if
unidimensionality is tenable” [33, p. 192].
The point-measure correlation (PTMEA) ranges from +1
to -1 “with negative items suggesting improper scoring or
not functioning as expected” [33, p. 192]. An inspection of
the PTMEAs for the SF-36 total scale indicated that items
GH01:Q1, SF01:Q6, BP01:Q7, and VT02:Q9E had consistent
negative PTMEAs over the six waves of data collection. The
rest of the SF-36 total scale items had PTMEAs that were
positive, supporting item-level polarity. For all other items,
the PTMEA correlations had acceptable values.
The functioning of the six rating scale categories was
examined for the SF-36 total scale. Rating scale frequency
and percent indicated that all categories were used by the
participants. The category use statistics are presented in
Table 5. The category logit measures ranged from -3.19 to
2.86 (see Table 5). None of the infit MNSQ scores fell outside
the 0.7-1.30 range and/or a z-score that fell inside the +2 to
-2 range. The results indicated that the six-level rating scale
used in the SF-36 total scale fits appropriately to the predictive
RMM (see Supplemental Figure 2); however, the full range of
ratings were used by the participants who completed the SF-
36 total scale. The probability curves for the rating scales of
the six waves of data collection illustrated that each threshold
estimate represented a separate point on themeasure variable
and each response category was the most probable category
for some part of the continuum.
To investigate the possibility of item bias, differential
item functioning (DIF) analysis was conducted to determine
10 BioMed Research International
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whether different groups of participants based onmarital sta-
tus and area of residence (urban versus regional; see Table 6)
responded differently on the SF-36 total scale items, despite
having the same level of the latent trait being measured [34].
Three of the SF-36 items exhibited a consistent pattern of DIF
over the six waves of data collection for both marital status
and area of residence, those being MH01:Q9B, MH02:Q9C,
and MH05:Q9H. It should be noted that these three items
also exhibited MNSQ infit scores outside the 0.7-1.30 range
and/or a z-score that fell inside the +2 to -2 range.
3.2. SF36 Physical Health Scale Rasch Analysis for Six Waves
of Data Collection. The following SF-36 physical health
items were included in the initial analysis using the RMM:
GH01:Q1, PF01:Q3A, PF02:Q3B, PF03:Q3C, PF04:Q3D,
PF05:Q3E, PF06:Q3F, PF07:Q3G, PF08:Q3H, PF09:Q3I,
PF10:Q3J, RP01:Q4A, RP02:Q4B, RP03:Q4C, RP04:Q4D,
BP01:Q7, BP02:Q8, GH02:Q11A, GH03:Q11B, GH04:Q11C,
and GH05:Q11D (see Table 7). When the 21 SF-36 items
were calibrated using the RMM for the six waves of data
collection, the items were found to have MNSQ infit statistics
ranging from 0.18 to 2.66 and outfit statistics ranging from
0.19 to 2.77 (see Table 8). The mean item measure was 0.00
logits (SD = 0.99). With respect to logit measures, there was
a broad range, the lowest value being –2.49 and the highest
value being +1.79 (see Table 9). This resulted in an average
item separation index of 60.32 and an average reliability of
1.00 over the six waves of data collection (see Table 9). The
separation index for items was greater than 2.0 indicating
adequate separation of the items on the construct being
measured.
The SF-36 physical health scale person-item map is
located in Supplemental Figure 3 and reports evidence of
the hierarchical ordering of the SF-36 physical health scale
items. Items which are easier are located at the bottom of the
SF-36 physical health person-item map while more difficult
items are located at the top of the map. The patterns of more
challenging items and less difficult items on the person-item
map for each of the six waves of data collection appear to be
fairly consistent. It should also be noted that several of the SF-
36 physical health scale items have the same level of difficulty.
The average person measure was 1.91 logits (SD = 0.39)
over the six waves of data collection (see Table 9). The mean
person separation was 0.93 with a mean reliability of 0.46
(see Table 9).With amean person separation reliability of less
than 2.0, this indicates inadequate separation of participants
on the SF-36 physical health construct. When examining the
overall RMM output of the SF-36 physical health total scale,
the average person measure (1.91 logits) was higher than the
average item measure (0.00 logits). The range of logit values
for items was from+1.62 to -2.49 logits. The person reliability
was 0.46 and item reliability was 1.00. Reliability ranges of .80
or greater are generally considered desirable [35]. This places
the item reliability for the SF-36 physical health scale in the
acceptable range and the person reliability correlation in the
less than desired range.
The SF-36 physical health scale has a six-category rating
scale which generates five thresholds. Rasch analysis reports
the calibrations of the six thresholds increases monotonically
from -3.86, -2.13, -.83, .10, 1.96, and 5.32 for wave one and
-3.64, -2.02, -.91, .01, 2.00, and 5.24 for wave six.
Item fit to the unidimensionality requirement of the
RMM was also examined. Seven out of the 21 items were
found to have MNSQ infit and outfit statistics inside the
0.70 to 1.30 range and/or a z-score that fell inside the +2
to -2 range. Therefore items 1:Q1, PF01:Q3A, PF04:Q3D,
PF06:Q3F, PF07:Q3G, GH02:Q11A, and GH04:Q11C met
the RMM requirements (see Table 2). In other words,
only 7 / 21 or 52.4% of the SF-36 physical health scale
items met the RMM requirements. The following items
had an Infit MNSQ statistic that was less than 0.70:
PF02:Q3B, PF03:Q3C, PF05:Q3E, PF08:Q3H, PF09:Q3I,
PF10:Q3J, RP01:Q4A, RP02:Q4B,RP03:Q4C, and RP04:Q4D.
The following items had an Infit MNSQ statistic that
was greater than 1.30: BP01:Q7, BP02:Q8, GH03:Q11B, and
GH05:Q11D.
An inspection of the PTMEAs for the SF-36 physical
health scale indicated that itemsHG01:Q1, BP01:Q7, BP02:Q8,
and GH05:Q11D had consistent negative PTMEAs over the
six waves of data collection. For all other items, the PTMEA
correlations had acceptable values.
When the item residuals from the RMM output were
factor analysed, no significant factor loadings were present
(seeTable 10).This indicated that the unidimensional require-
ment of the SF-36 physical health scale was met. The raw
variance explained by the SF-36 physical health scale over
the six waves of data collection ranged from 41.6% to 48.9%
and the unexplained variance in the first contrast ranged from
17.4% to 22.4%.The residual analysis completed indicated that
no second dimension or factor existed.
The functioning of the six rating scale categories was
examined for the SF-36 physical health scale. The category
logit measures ranged from -3.86 to 5.43 (see Table 11). Of
the six rating scale categories, only one had infit MNSQ
scores that fell outside the 0.7-1.30 range and/or a z-score
that fell inside the +2 to -2 range over the six waves of data
collection, this being category six. The infit MNSQ scores for
this rating category ranged from 2.03 to 3.18 (see Table 11).
The results indicated that the six-level rating scale used in
the SF-36 physical health scale might not be the most robust
to use (see Supplemental Figure 3); however, the full range
of ratings were used by the participants who completed the
SF-36 physical health scale. The probability curves for the
rating scales of the six waves of data collection illustrated that
each threshold estimate represented a separate point on the
measure variable and the first five response categories were
the most probable category for some part of the continuum.
Rating category six was problematic.
The Rasch output logit performance scores for the par-
ticipants were compared to determine if any of the SF-36
physical scale items exhibited differential item functioning
(DIF), based on marital status and area of residence (urban
versus regional) (see Table 12). Four of the SF-36 physical
health items exhibited a consistent pattern of DIF over the
six waves of data collection. Item PF03:Q3C demonstrated
DIF based on marital status alone while items GH02:Q11A,
GH04:Q11C, and GH05:Q11D exhibited DIF based on both
marital status and area of residence (see Table 12). It should
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Table 9: SF-36 physical health scale Rasch analysis summary Item and Person Infit and Outfit statistics for six waves of data collection.
Wave 1 Wave 2 Wave 3 Wave 4 Wave 5 Wave 6
Persons MEAN -1.77 -1.85 -1.90 -1.92 -1.95 -2.07
S.D. .38 .37 .40 .39 .39 .40
MAX 1.54 -.37 .40 .92 -.52 .40
MIN -5.13 -4.11 -.09 -5.08 -4.52 -.79
Infit-MNSQ 1.05 1.04 1.05 1.05 1.05 1.05
Infit-ZSTD -.10 -.20 -.10 .00 .00 .00
Outfit-MNSQ 1.00 1.01 .98 .97 .96 .96
Outfit-ZSTD -.30 -.30 -.30 -.20 -.20 -.20
Person separation .86c .88c .97c .96c .96c .96c
Person reliability .43a .43a .48a .48a .48a .48a
Items MEAN .00 .00 .00 .00 .00 .00
S.D. .91 .99 .98 1.00 1.02 1.08
MAX 1.62 1.58 1.63 1.64 1.63 1.79
MIN -2.22 -2.49 -2.46 -2.45 -2.43 -2.49
Infit-MNSQ .95 .98 .95 .94 .94 .95
Infit-ZSTD -3.00 -3.00 -3.10 -3.40 -3.40 -3.30
Outfit-MNSQ .98 1.00 .96 .95 .94 .94
Outfit-ZSTD -3.10 -3.40 -3.50 -3.60 -3.70 -3.60
Item separation 71.24 69.37 63.25 59.41 52.87 45.77
Item reliability 1.00 1.00 1.00 1.00 1.00 1.00
Notes. aPerson or item reliability <0.8; bItem separation <3.0; cPerson separation <2.0; values in italic for Infit or Outfit MnSq > 1.34; values underlined for
Infit or Outfit MnSq < 0.64.
be noted that items GH02:Q11A and GH04:Q11C had infit
MNSQ statistics that fell within the 0.70-1.30 range while
items PF03:Q3C and GH05:Q11D also hadMNSQ infit scores
outside the 0.7-1.30 range and/or a z-score that fell inside
the +2 to -2 range. SF-36 physical health items PF03:Q3C
and GH05:Q11D appear to be particularly problematic items
based on the RMM analysis findings.
3.3. SF36 Mental Health Scale Rasch Analysis for Six Waves
of Data Collection. The following SF-36 mental health items
were included in the initial analysis using the RMM:
RE01:Q5A, RE02:Q5B, RE03:Q5C, SF01:Q6, VT01:Q9A,
24MH01:Q9B, MH02:Q9C, MH03:Q9D, VT02:Q9E, MH04:
Q9F, VT03:Q9G, MH05:Q9H, VT04:Q9I, and SF02:Q10.
When the 14 SF-36 mental health items were calibrated using
the RMM for the six waves of data collection, the items
were found to have MNSQ infit statistics ranging from 0.13
to 2.43 and outfit statistics ranging from 0.22 to 2.64 (see
Table 13).Themean itemmeasure was 0.00 logits (SD = 1.12).
With respect to logit measures, there was a broad range, the
lowest value being –3.01 and the highest value being +2.31 (see
Table 14).This resulted in an average item separation index of
79.17 and an average reliability of 1.00 over the six waves (see
Table 15).The separation index for items was greater than 2.0
indicating adequate separation of the items on the construct
being measured.
The SF-36 mental health scale person-itemmap is shown
in Supplemental Figure 5 and reports evidence of the
hierarchical ordering of the SF-36 mental health scale items.
It should also be noted that several of the SF-36mental health
scale items have the same level of difficulty. The average
personmeasure was 0.75 logits (SD = 0.23) over the six waves
of data collection (see Table 15). The mean person separation
was 0.73 with a mean reliability of 0.35 (see Table 15). With
a mean person separation reliability of less than 2.0, this
indicates inadequate separation of participants on the SF-36
mental health construct.
When examining the overall RMM output of the SF-36
mental health scale, the average person measure (0.75 logits)
was higher than the average item measure (0.00 logits). The
range of logit values for items was from +2.13 to -2.08 logits.
The person reliability was 0.35 and item reliability was 1.00.
Reliability ranges of .80 or greater are generally considered
desirable [35]. This places the item reliability for the SF-36
mental health scale in the acceptable range and the person
reliability correlation in the less than desired range.
The SF-36 mental health scale has a six-category rating
scale which generates five thresholds. Rasch analysis reports
the calibrations of the six thresholds increases monotonically
from -3.07, -1.06, -.17, .40, 1.14, and 2.54 for wave one and
-2.98, -1.09, -.19, .41, 1.15, and 2.51 for wave six.
Item fit to the unidimensionality requirement of the
RMMwas also examined. Five out of the 14 items were found
to have MNSQ infit and outfit statistics inside the 0.70 to 1.30
range and/or a z-score that fell inside the +2 to -2 range; thus,
items VT01:Q9A, MH01:Q9B, MH03:Q9D, 27VT02:Q9E,
MH04:Q9F, VT03:Q9G, MH05:Q9H, VT04:Q9I, and
SF02:Q10met the RMM requirements (see Table 14). In other
words, only 9/14 or 64.3% of the SF-36 physical health scale
items met the RMM requirements. The following items had
18 BioMed Research International
Ta
bl
e
10
:S
F-
36
ph
ys
ic
al
he
al
th
sc
al
eR
as
ch
an
al
ys
is
of
sta
nd
ar
di
se
d
re
sid
ua
lv
ar
ia
nc
ei
n
Ei
ge
nv
al
ue
un
its
fo
rs
ix
w
av
es
of
da
ta
co
lle
ct
io
n.
W
av
e1
W
av
e2
W
av
e3
Ei
ge
nv
al
ue
O
bs
er
ve
d
Ex
pe
ct
ed
Ei
ge
nv
al
ue
O
bs
er
ve
d
Ex
pe
ct
ed
Ei
ge
nv
al
ue
O
bs
er
ve
d
Ex
pe
ct
ed
To
ta
lr
aw
va
ri
an
ce
in
ob
se
rv
at
io
ns
36
.0
7
10
0.
00
%
10
0.
00
%
36
.0
7
10
0.
00
%
10
0.
00
%
37
.8
9
10
0.
00
%
10
0.
00
%
Ra
w
va
ri
an
ce
ex
pl
ai
ne
d
by
m
ea
su
re
s
15
.0
7
41
.8
0%
42
.5
0%
15
.0
7
41
.8
0%
42
.5
0%
16
.8
9
44
.6
0%
45
.7
0%
Ra
w
va
ri
an
ce
ex
pl
ai
ne
d
by
pe
rs
on
s
1.9
0
5.
30
%
5.
40
%
1.9
0
5.
30
%
5.
40
%
0.
96
2.
50
%
2.
60
%
Ra
w
Va
ri
an
ce
ex
pl
ai
ne
d
by
ite
m
s
13
.16
36
.5
0%
37
.10
%
13
.16
36
.5
0%
37
.10
%
15
.9
4
42
.10
%
43
.10
%
Ra
w
un
ex
pl
ai
ne
d
va
ri
an
ce
(to
ta
l)
21
.0
0
58
.2
0%
57
.5
0%
21
.0
0
58
.2
0%
57
.5
0%
21
.0
0
55
.4
0%
54
.3
0%
U
ne
xp
la
in
ed
va
ri
an
ce
in
1s
tc
on
tr
as
t
8.
00
22
.2
0%
38
.10
%
8.
00
22
.2
0%
38
.10
%
7.7
0
20
.3
0%
36
.7
0%
U
ne
xp
la
in
ed
va
ri
an
ce
in
2n
d
co
nt
ra
st
2.
02
5.
60
%
9.6
0%
2.
02
5.
60
%
9.6
0%
1.9
6
5.
20
%
9.4
0%
U
ne
xp
la
in
ed
va
ri
an
ce
in
3r
d
co
nt
ra
st
1.5
1
4.
20
%
7.2
0%
1.5
1
4.
20
%
7.2
0%
1.4
4
3.
80
%
6.
90
%
U
ne
xp
la
in
ed
va
ri
an
ce
in
4t
h
co
nt
ra
st
1.3
1
3.
60
%
6.
20
%
1.3
1
3.
60
%
6.
20
%
1.2
3
3.
20
%
5.
80
%
U
ne
xp
la
in
ed
va
ri
an
ce
in
5t
h
co
nt
ra
st
0.
99
2.
80
%
4.
70
%
0.
99
2.
80
%
4.
70
%
0.
99
2.
60
%
4.
70
%
W
av
e4
W
av
e5
W
av
e6
Ei
ge
nv
al
ue
O
bs
er
ve
d
Ex
pe
ct
ed
Ei
ge
nv
al
ue
O
bs
er
ve
d
Ex
pe
ct
ed
Ei
ge
nv
al
ue
O
bs
er
ve
d
Ex
pe
ct
ed
To
ta
lr
aw
va
ri
an
ce
in
ob
se
rv
at
io
ns
37
.0
7
10
0.
00
%
10
0.
00
%
39
.3
4
10
0.
00
%
10
0.
00
%
41
.0
8
10
0.
00
%
10
0.
00
%
Ra
w
va
ri
an
ce
ex
pl
ai
ne
d
by
m
ea
su
re
s
17.
07
46
.10
%
48
.0
0%
18
.3
4
46
.6
0%
48
.6
0%
20
.0
8
48
.9
0%
51
.10
%
Ra
w
va
ri
an
ce
ex
pl
ai
ne
d
by
pe
rs
on
s
2.
45
6.
60
%
6.
90
%
2.
42
6.
10
%
6.
40
%
2.
68
6.
50
%
6.
80
%
Ra
w
Va
ri
an
ce
ex
pl
ai
ne
d
by
ite
m
s
14
.6
2
39
.4
0%
41
.10
%
15
.9
2
40
.5
0%
42
.2
0%
17.
40
42
.3
0%
44
.2
0%
Ra
w
un
ex
pl
ai
ne
d
va
ri
an
ce
(to
ta
l)
20
.0
0
53
.9
0%
52
.0
0%
21
.0
0
53
.4
0%
51
.4
0%
21
.0
0
51
.10
%
48
.9
0%
U
ne
xp
la
in
ed
va
ri
an
ce
in
1s
tc
on
tr
as
t
6.
64
17.
90
%
33
.2
0%
7.5
0
19
.10
%
35
.7
0%
7.1
4
17.
40
%
34
.0
0%
U
ne
xp
la
in
ed
va
ri
an
ce
in
2n
d
co
nt
ra
st
2.
10
5.
70
%
10
.5
0%
2.
06
5.
20
%
9.8
0%
2.
24
5.
50
%
10
.7
0%
U
ne
xp
la
in
ed
va
ri
an
ce
in
3r
d
co
nt
ra
st
1.5
4
4.
20
%
7.7
0%
1.5
8
4.
00
%
7.5
0%
1.5
6
3.
80
%
7.4
0%
U
ne
xp
la
in
ed
va
ri
an
ce
in
4t
h
co
nt
ra
st
1.2
6
3.
40
%
6.
30
%
1.2
1
3.
10
%
5.
80
%
1.2
0
2.
90
%
5.
70
%
U
ne
xp
la
in
ed
va
ri
an
ce
in
5t
h
co
nt
ra
st
1.0
7
2.
90
%
5.
30
%
1.0
3
2.
60
%
4.
90
%
1.0
4
2.
50
%
4.
90
%
No
tes
.a
>
60
%
un
ex
pl
ai
ne
d
va
ria
nc
ei
n
th
eR
as
ch
fa
ct
or
;b
Ei
ge
nv
al
ue
in
th
efi
rs
tc
on
tr
as
t<
3.
0;
c
<
10
%
un
ex
pl
ai
ne
d
va
ria
nc
ei
n
th
efi
rs
tc
on
tr
as
t.
BioMed Research International 19
Ta
bl
e
11:
SF
-3
6
ph
ys
ic
al
he
al
th
sc
al
eR
as
ch
an
al
ys
is
of
su
m
m
ar
y
of
ca
te
go
ry
str
uc
tu
re
fo
rs
ix
w
av
es
of
da
ta
co
lle
ct
io
n.
W
AV
E
1
W
AV
E
2
W
AV
E
3
CA
T.
LA
BE
L
N
%
Av
er
ag
e
M
ea
-
su
re
s
In
fit
M
nS
q
O
ut
fit
M
nS
q
A
nd
ri
ch

re
sh
-
ol
ds
N
%
Av
er
ag
e
M
ea
-
su
re
s
In
fit
M
nS
q
O
ut
fit
M
nS
q
A
nd
ri
ch

re
sh
-
ol
ds
N
%
Av
er
ag
e
M
ea
-
su
re
s
In
fit
M
nS
q
O
ut
fit
M
nS
q
A
nd
ri
ch

re
sh
-
ol
ds
1
60
72
1
23
(-
3.
86
)
1.1
8
1.1
1
N
O
N
E
55
35
0
25
(-
3.
92
)
1.1
2
1.0
7
N
O
N
E
46
99
5
28
(-
3.
86
)
1.1
4
1.0
8
N
O
N
E
2
83
03
9
32
-2
.13
.9
3
.9
4
-2
.5
6
70
45
4
32
-2
.19
.9
3
.9
2
-2
.6
0
54
69
2
32
-2
.17
1.0
0
.9
9
-2
.5
4
3
73
29
9
28
-.8
3
.6
6
.5
9
-1
.5
4
62
78
0
29
-.8
5
.6
6
.6
0
-1
.6
1
46
90
5
28
-.9
0
.7
2
.6
2
-1
.6
1
4
12
95
7
5
.10
1.1
9
1.2
6
.5
9
113
89
5
.14
1.2
1
1.3
8
.53
97
20
6
.0
7
1.1
1
1.1
1
.3
8
5
15
14
4
6
1.9
6
1.0
5
1.1
5
-.7
1
b
12
63
4
6
2.
03
1.1
3
1.3
3
-.5
5
b
99
42
6
2.
05
1.0
8
1.1
7
-.5
6
b
6
23
8
0
(5
.32
)
2.
67
2.
61
4.
21
23
3
0
(5
.3
4)
3.
18
2.
98
4.
23
15
5
0
(5
.4
3)
2.
77
2.
30
4.
33
W
AV
E
4
W
AV
E
5
W
AV
E
6
CA
T.
LA
BE
L
N
%
Av
er
ag
e
M
ea
-
su
re
s
In
fit
M
nS
q
O
ut
fit
M
nS
q
A
nd
ri
ch

re
sh
-
ol
ds
N
%
Av
er
ag
e
M
ea
-
su
re
s
In
fit
M
nS
q
O
ut
fit
M
nS
q
A
nd
ri
ch

re
sh
-
ol
ds
N
%
Av
er
ag
e
M
ea
-
su
re
s
In
fit
M
nS
q
O
ut
fit
M
nS
q
A
nd
ri
ch

re
sh
-
ol
ds
1
42
92
4
29
(-
3.
75
)
1.1
5
1.0
8
N
O
N
E
36
50
2
31
(-
3.
66
)
1.1
5
1.0
8
N
O
N
E
28
78
7
36
(-
3.
64
)
1.1
5
1.0
8
N
O
N
E
2
44
60
3
30
-2
.0
9
1.0
5
1.0
2
-2
.4
2
33
75
1
29
-2
.0
1
1.0
8
1.0
1
-2
.33
23
23
3
29
-2
.0
2
1.1
0
1.0
1
-2
.3
0
3
36
07
1
24
-.8
9
.76
.6
4
-1
.52
25
38
9
22
-.8
7
.8
2
.6
8
-1
.4
4
16
93
0
21
-.9
1
.8
6
.7
3
-1
.4
6
4
89
58
6
.0
6
1.0
0
.9
6
.2
4
73
10
6
.0
6
.9
4
.8
6
.13
53
53
7
.0
1
.9
1
.8
0
.0
3
5
85
92
6
2.
01
1.1
0
1.1
6
-.4
8
b
64
64
6
1.9
6
1.0
9
1.1
2
-.3
8
b
46
94
6
2.
00
1.0
9
1.1
0
-.3
9
b
6
15
0
0
(5
.2
9)
2.
54
2.
02
4.
18
12
9
0
(5
.12
)
2.
25
1.7
5
4.
02
80
0
(5
.2
4)
2.
03
1.5
2
4.
13
No
tes
.a A
nd
ric
h
th
re
sh
ol
d
ca
te
go
ry
in
cr
ea
se
of
>
5;
b A
nd
ric
h
th
re
sh
ol
d
ca
te
go
ry
de
cr
ea
se
w
he
re
an
in
cr
ea
se
is
ex
pe
ct
ed
;v
al
ue
si
n
ita
lic
fo
rI
nfi
to
rO
ut
fit
M
nS
q
>
1.3
4;
va
lu
es
un
de
rli
ne
d
fo
rI
nfi
to
rO
ut
fit
M
nS
q
<
0.
64
.
20 BioMed Research International
Ta
bl
e
12
:D
iff
er
en
tia
lI
te
m
Fu
nc
tio
ni
ng
(D
IF
)f
or
SF
-3
6
ph
ys
ic
al
he
al
th
sc
al
eR
as
ch
an
al
ys
is
fo
rs
ix
w
av
es
of
da
ta
co
lle
ct
io
n
ba
se
d
on
m
ar
ita
ls
ta
tu
sa
nd
ar
ea
of
re
sid
en
ce
.
W
av
e1
W
av
e2
W
av
e3
M
ar
ita
ls
ta
tu
s
Ur
ba
n
an
d
Re
gi
on
al
M
ar
ita
ls
ta
tu
s
Ur
ba
n
an
d
Re
gi
on
al
M
ar
ita
ls
ta
tu
s
Ur
ba
n
an
d
Re
gi
on
al
SF
36
IT
EM
N
o.
SU
M
D
IF
CH
I-
SQ
UA
RE
(D
IF
=
2)
PR
O
B.
D
IF
CO
N
TR
AS
T
M
an
te
l-
H
ae
ns
ze
l
Pr
ob
ab
ili
ty
SU
M
D
IF
CH
I-
SQ
UA
RE
(D
IF
=
2)
PR
O
B
D
IF
CO
N
TR
AS
T
M
an
te
l-
H
ae
ns
ze
l
Pr
ob
ab
ili
ty
SU
M
D
IF
CH
I-
SQ
UA
RE
(D
IF
=
2)
PR
O
B
D
IF
CO
N
TR
AS
T
M
an
te
l-
H
ae
ns
ze
l
Pr
ob
ab
ili
ty
1:Q
1
13
.2
5
.0
01
∗
∗
∗
0.
00
.6
39
1.6
2
.4
42
0.
14
.7
13
0.
41
.8
16
0.
00
.18
5
3:
Q
3A
5.
79
.0
54
0.
00
.72
5
1.2
7
.52
7
0.
00
.33
0
5.
69
.0
57
0.
00
.0
73
4:
Q
3B
1.9
4
.37
6
0.
00
.0
69
0.
56
.75
4
0.
15
.8
35
0.
50
.7
79
0.
06
.0
01
∗
∗
∗
5:
Q
3C
1.8
4
.39
4
0.
06
.0
01
∗
∗
∗
0.
03
.9
84
0.
00
.0
09
∗
∗
0.
56
.75
6
0.
00
.4
42
6:
Q
3D
0.
97
.6
14
0.
00
.9
47
2.
13
.3
42
-0
.2
0
.7
78
0.
44
.8
04
0.
00
.7
00
7:
Q
3E
0.
41
.8
16
0.
00
.2
87
2.
75
.2
50
0.
00
.15
3
1.2
6
.52
9
0.
00
.14
3
8:
Q
3F
0.
06
.9
70
0.
00
.6
84
0.
18
.9
17
-0
.0
8
.59
9
0.
03
.9
88
-0
.0
4
.9
64
9:
Q
3G
13
.16
.0
01
∗
∗
∗
-0
.0
2
.0
76
1.3
3
.51
2
0.
03
.0
06
∗
∗
0.
57
.75
0
0.
00
.8
47
10
:Q
3H
12
.78
.0
02
∗
∗
0.
00
.32
4
5.7
2
.0
56
-0
.2
2
.32
0
0.
02
.9
90
0.
00
.2
25
11
:Q
3I
7.4
5
.0
24
∗
0.
00
.35
7
5.5
5
.0
61
0.
07
.0
01
∗
∗
∗
0.
00
1.0
00
0.
00
.6
31
12
:Q
3J
0.
95
.6
20
0.
00
.3
06
0.
03
.9
88
-0
.0
3
.8
36
0.
73
.6
93
0.
00
.2
51
13
:Q
4A
2.
34
.3
06
0.
00
.51
9
0.
08
.9
62
0.
00
.4
61
0.
17
.9
19
0.
00
.3
60
14
:Q
4B
1.4
5
.4
81
0.
00
.78
2
4.
22
.11
9
-0
.3
0
.2
06
6.
61
.0
36
∗
0.
00
.52
0
15
:Q
4C
2.
47
.2
88
0.
00
.9
82
0.
08
.9
61
0.
00
.24
0
0.
37
.8
31
0.
00
.52
4
16
:Q
4D
0.
08
.9
65
0.
00
.8
45
0.
06
.9
73
0.
00
.8
73
4.
54
.10
1
0.
00
.0
53
21
:Q
7
2.
54
.2
77
-0
.0
5
.0
05
∗
∗
9.3
4
.0
09
∗
∗
0.
00
.13
1
0.
13
.9
41
0.
00
.14
5
22
:Q
8
37
.2
9
.0
01
∗
∗
∗
0.
00
.11
4
1.0
0
.6
05
-0
.0
9
.6
51
1.8
5
.39
4
0.
02
.0
81
33
:Q
11
A
27
.3
.0
01
∗
∗
∗
0.
07
.0
01
∗
∗
∗
1.1
1
.57
2
0.
00
.52
1
0.
02
.9
90
0.
00
.2
75
34
:Q
11
B
36
.3
8
.0
01
∗
∗
∗
0.
00
.9
05
1.4
1
.4
90
-0
.2
0
.3
09
6.
66
.0
35
∗
0.
00
.17
0
35
:Q
11
C
12
.2
.0
02
∗
∗
0.
00
.2
04
0.
68
.7
10
0.
00
.9
63
0.
58
.74
9
-0
.0
5
.0
02
∗
∗
36
:Q
11
D
35
.2
9
.0
01
∗
∗
∗
-0
.0
5
.0
06
∗
∗
1.3
8
.5
00
0.
12
.4
44
7.0
3
.0
29
∗
0.
00
.72
4
W
av
e4
W
av
e5
W
av
e6
M
ar
ita
ls
ta
tu
s
Ur
ba
n
an
d
Re
gi
on
al
M
ar
ita
ls
ta
tu
s
Ur
ba
n
an
d
Re
gi
on
al
M
ar
ita
ls
ta
tu
s
Ur
ba
n
an
d
Re
gi
on
al
SF
36
IT
EM
N
o.
SU
M
D
IF
CH
I-
SQ
UA
RE
(D
IF
=
2)
PR
O
B
D
IF
CO
N
TR
AS
T
M
an
te
l-
H
ae
ns
ze
l
Pr
ob
ab
ili
ty
SU
M
D
IF
CH
I-
SQ
UA
RE
(D
IF
=
2)
PR
O
B
D
IF
CO
N
TR
AS
T
M
an
te
l-
H
ae
ns
ze
l
Pr
ob
ab
ili
ty
SU
M
D
IF
CH
I-
SQ
UA
RE
(D
IF
=
2)
PR
O
B
D
IF
CO
N
TR
AS
T
M
an
te
l-
H
ae
ns
ze
l
Pr
ob
ab
ili
ty
1:Q
1
0.
67
.7
14
0.
00
.18
5
4.
44
.10
7
0.
23
.7
07
2.
87
.2
35
0.
09
.4
18
3:
Q
3A
0.
22
.8
97
0.
00
.0
73
1.3
2
.51
5
0.
00
.37
5
3.7
3
.15
3
0.
00
.17
6
4:
Q
3B
0.
26
.8
78
0.
06
.0
01
∗
∗
∗
0.
59
.74
4
0.
34
.2
29
2.
71
.2
54
0.
38
.0
98
5:
Q
3C
3.4
8
.17
3
0.
00
.4
42
0.
65
.72
0
0.
00
.3
42
1.8
1
.4
00
-0
.13
.2
70
6:
Q
3D
1.3
9
.4
96
0.
00
.7
00
2.
83
.24
0
-0
.16
.57
3
7.8
5
.0
19
∗
0.
00
.76
1
7:
Q
3E
0.
10
.9
53
0.
00
.14
3
1.7
3
.4
18
0.
03
.0
25
∗
6.
17
.0
45
∗
0.
00
.2
78
8:
Q
3F
2.
31
.31
1
-0
.0
4
.9
64
0.
00
1.0
00
-0
.17
.4
56
0.
43
.8
08
-0
.0
8
.24
8
9:
Q
3G
0.
95
.6
21
0.
00
.8
47
0.
39
.8
24
0.
12
.0
01
∗
∗
∗
1.2
0
.5
47
0.
11
.0
01
∗
∗
∗
10
:Q
3H
1.8
9
.3
84
0.
00
.2
25
0.
73
.6
95
-0
.2
6
.4
43
0.
68
.7
12
-0
.12
.73
9
11
:Q
3I
0.
00
1.0
00
0.
00
.6
31
0.
42
.8
09
0.
00
.9
61
0.
55
.76
1
0.
00
.3
87
12
:Q
3J
0.
05
.9
75
0.
00
.2
51
0.
10
.9
53
0.
06
.2
52
0.
65
.72
2
-0
.0
3
.6
64
13
:Q
4A
0.
45
.7
98
0.
00
.3
60
0.
00
1.0
00
-0
.0
6
.0
42
∗
0.
17
.9
22
-0
.0
7
.2
82
14
:Q
4B
1.6
0
.4
47
0.
00
.52
0
1.9
8
.3
67
-0
.0
5
.8
61
0.
82
.6
63
-0
.12
.13
8
15
:Q
4C
2.
50
.2
83
0.
00
.52
4
0.
01
.9
96
0.
00
.4
53
0.
20
.9
08
0.
00
.2
55
16
:Q
4D
0.
68
.7
11
0.
00
.0
53
0.
24
.8
89
-0
.0
6
.73
3
0.
73
.6
92
0.
02
.4
31
21
:Q
7
3.6
1
.16
2
0.
00
.14
5
0.
00
1.0
00
-0
.0
6
.4
13
1.7
5
.4
13
-0
.0
7
.6
50
22
:Q
8
1.0
3
.59
5
0.
02
.0
81
3.0
3
.2
17
0.
00
.31
0
4.
23
.11
9
-0
.10
.6
44
33
:Q
11
A
0.
14
.9
34
0.
00
.2
75
13
.7
7
.0
01
∗
∗
∗
-0
.0
5
.17
0
1.3
4
.5
09
-0
.0
7
.72
9
34
:Q
11
B
4.
03
.13
1
0.
00
.17
0
1.8
0
.4
03
0.
20
.0
48
∗
2.
28
.31
7
0.
07
.2
52
35
:Q
11
C
0.
00
1.0
00
-0
.0
5
.0
02
∗
∗
0.
49
.78
3
0.
00
.2
80
3.6
8
.15
6
0.
00
.6
81
36
:Q
11
D
0.
37
.8
31
0.
00
.72
4
7.4
8
.0
23
∗
0.
00
.9
41
1.5
5
.4
57
-0
.0
3
.8
97
No
tes
.P
RO
B.
=
pr
ob
ab
ili
ty
;∗
𝑝
≤
.0
5;
∗
∗
p
≤
.0
1;
∗
∗
∗
p
≤
.0
01
.
BioMed Research International 21
Ta
bl
e
13
:S
F-
36
m
en
ta
lh
ea
lth
sc
al
eR
as
ch
an
al
ys
is
ite
m
sta
tis
tic
sf
or
six
w
av
es
of
da
ta
co
lle
ct
io
n.
W
av
e1
W
av
e2
W
av
e3
SF
36
IT
EM
M
EA
SU
RE
M
O
D
EL
S.
E.
PT
M
EA
C
O
RR
.
M
EA
SU
RE
M
O
D
EL
S.
E.
PT
M
EA
C
O
RR
.
M
EA
SU
RE
M
O
D
EL
S.
E.
PT
M
EA
C
O
RR
17
:Q
5A
1.3
5
0.
01
0.
31
1.3
8
0.
01
0.
30
1.4
9
0.
02
0.
27
18
:Q
5B
1.5
7
0.
01
0.
31
1.6
2
0.
02
0.
29
1.7
5
0.
02
0.
27
19
:Q
5C
1.3
8
0.
01
0.
30
1.4
1
0.
01
0.
28
1.5
0
0.
02
0.
26
20
:Q
6
1.5
1
0.
01
-0
.0
9
1.7
8
0.
02
-0
.0
2
1.4
1
0.
01
-0
.0
2
23
:Q
9A
-0
.0
3
0.
01
0.
17
-0
.0
6
0.
01
0.
22
-0
.12
0.
01
0.
27
24
:Q
9B
-1
.2
8
0.
01
0.
46
-1
.4
7
0.
01
0.
43
-1
.5
4
0.
01
0.
41
25
:Q
9C
-1
.8
4
0.
01
0.
45
-2
.0
4
0.
01
0.
40
-2
.0
8
0.
02
0.
40
26
:Q
9D
0.
21
0.
01
0.
20
0.
30
0.
01
0.
18
0.
30
0.
01
0.
26
27
:Q
9E
-0
.16
0.
01
0.
22
-0
.2
4
0.
01
0.
26
-0
.2
9
0.
01
0.
30
28
:Q
9F
-1
.2
5
0.
01
0.
46
-1
.33
0.
01
0.
39
-1
.32
0.
01
0.
40
29
:Q
9G
-0
.9
0
0.
01
0.
44
-0
.9
3
0.
01
0.
39
-0
.8
8
0.
01
0.
39
30
:Q
9H
0.
63
0.
01
0.
27
0.
72
0.
01
0.
25
0.
74
0.
01
0.
28
31
:Q
9I
-0
.5
5
0.
01
0.
37
-0
.5
0
0.
01
0.
31
-0
.4
2
0.
01
0.
31
32
:Q
10
-0
.6
5
0.
01
0.
28
-0
.6
5
0.
01
0.
22
-0
.5
5
0.
01
0.
19
W
av
e4
W
av
e5
W
av
e6
SF
36
IT
EM
M
EA
SU
RE
M
O
D
EL
S.
E.
PT
M
EA
C
O
RR
M
EA
SU
RE
M
O
D
EL
S.
E.
PT
M
EA
C
O
RR
M
EA
SU
RE
M
O
D
EL
S.
E.
PT
M
EA
C
O
RR
.
17
:Q
5A
1.4
7
0.
02
0.
28
1.4
8
0.
02
0.
30
1.5
1
0.
02
0.
29
18
:Q
5B
1.7
6
0.
02
0.
28
1.7
7
0.
02
0.
30
1.8
1
0.
03
0.
32
19
:Q
5C
1.5
1
0.
02
0.
27
1.5
1
0.
02
0.
28
1.5
3
0.
02
0.
28
20
:Q
6
1.1
9
0.
01
0.
04
1.0
1
0.
02
0.
03
0.
96
0.
02
0.
05
23
:Q
9A
-0
.14
0.
01
0.
23
-0
.2
1
0.
01
0.
24
-0
.2
9
0.
01
0.
26
24
:Q
9B
-1
.52
0.
01
0.
40
-1
.4
9
0.
02
0.
40
-1
.4
7
0.
02
0.
37
25
:Q
9C
-2
.0
7
0.
02
0.
35
-1
.9
2
0.
02
0.
39
-1
.9
1
0.
02
0.
35
26
:Q
9D
0.
30
0.
01
0.
23
0.
31
0.
01
0.
19
0.
29
0.
01
0.
22
27
:Q
9E
-0
.3
4
0.
01
0.
27
-0
.4
1
0.
01
0.
27
-0
.53
0.
01
0.
29
28
:Q
9F
-1
.3
0
0.
01
0.
40
-1
.2
5
0.
01
0.
42
-1
.2
2
0.
02
0.
41
29
:Q
9G
-0
.8
0
0.
01
0.
39
-0
.7
5
0.
01
0.
44
-0
.7
2
0.
01
0.
43
30
:Q
9H
0.
75
0.
01
0.
29
0.
69
0.
01
0.
23
0.
69
0.
02
0.
27
31
:Q
9I
-0
.3
4
0.
01
0.
33
-0
.3
0
0.
01
0.
35
-0
.2
7
0.
01
0.
32
32
:Q
10
-0
.4
8
0.
01
0.
17
-0
.4
4
0.
01
0.
17
-0
.39
0.
01
0.
17
No
te
:M
O
D
EL
S.
E.
=
M
od
el
St
an
da
rd
Er
ro
r;
PT
M
EA
CO
RR
=
Po
in
tM
ea
su
re
C
or
re
la
tio
n.
22 BioMed Research International
Ta
bl
e
14
:S
F-
36
m
en
ta
lh
ea
lth
sc
al
eR
as
ch
an
al
ys
is
In
fit
an
d
O
ut
fit
sta
tis
tic
sf
or
six
w
av
es
of
da
ta
co
lle
ct
io
n.
W
av
e1
W
av
e2
W
av
e3
SF
36
IT
EM
In
fit
O
ut
fit
In
fit
O
ut
fit
In
fit
O
ut
fit
M
N
SQ
ZS
TD
M
N
SQ
ZS
TD
M
N
SQ
ZS
TD
M
N
SQ
ZS
TD
M
N
SQ
ZS
TD
M
N
SQ
ZS
TD
17
:Q
5A
0.
29
-9
.9
0.
32
-9
.9
0.
26
-9
.9
0.
28
-9
.9
0.
30
-9
.9
0.
32
-9
.9
18
:Q
5B
0.
43
-9
.9
0.
46
-9
.9
0.
43
-9
.9
0.
46
-9
.9
0.
48
-9
.9
0.
50
-9
.9
19
:Q
5C
0.
31
-9
.9
0.
34
-9
.9
0.
29
-9
.9
0.
31
-9
.9
0.
32
-9
.9
0.
34
-9
.9
20
:Q
6
2.
64
9.9
2.
87
9.9
2.
91
9.9
3.
06
9.9
2.
54
9.9
2.
74
9.9
23
:Q
9A
1.0
8
7.7
1.1
5
9.9
1.0
3
3.
2
1.1
2
9.9
1.0
4
3.
5
1.0
9
6.
7
24
:Q
9B
1.2
5
9.9
1.1
7
9.9
1.4
0
9.9
1.2
9
9.9
1.4
1
9.9
1.3
1
9.9
25
:Q
9C
1.4
4
9.9
1.3
0
9.9
1.5
9
9.9
1.3
9
9.
9
1.5
1
9.9
1.3
3
9.9
26
:Q
9D
1.2
2
9.9
1.3
3
9.9
1.1
4
9.9
1.2
8
9.9
1.1
0
7.1
1.1
9
9.9
27
:Q
9E
1.1
2
9.9
1.1
7
9.9
1.0
8
7.8
1.1
2
9.9
1.0
7
5.
3
1.0
8
6.
3
28
:Q
9F
0.
90
-6
.6
0.
88
-8
.3
1.0
2
1.0
0.
98
-0
.9
0.
96
-2
.0
0.
93
-3
.6
29
:Q
9G
0.
88
-9
.9
0.
87
-9
.9
0.
90
-7
.4
0.
89
-7
.8
0.
88
-7
.8
0.
87
-8
.2
30
:Q
9H
1.2
2
9.9
1.2
9
9.9
1.1
5
8.
5
1.2
4
9.9
1.0
9
4.
6
1.1
6
7.9
31
:Q
9I
0.
72
-9
.9
0.
73
-9
.9
0.
76
-9
.9
0.
77
-9
.9
0.
73
-9
.9
0.
74
-9
.9
32
:Q
10
0.
72
-9
.9
0.
77
-9
.9
0.
78
-9
.9
0.
81
-9
.9
0.
87
-9
.9
0.
91
-6
.8
W
av
e4
W
av
e5
W
av
e6
SF
36
IT
EM
In
fit
O
ut
fit
In
fit
O
ut
fit
In
fit
O
ut
fit
M
N
SQ
ZS
TD
M
N
SQ
ZS
TD
M
N
SQ
ZS
TD
M
N
SQ
ZS
TD
M
N
SQ
ZS
TD
M
N
SQ
ZS
TD
17
:Q
5A
0.
31
-9
.9
0.
34
-9
.9
0.
34
-9
.9
0.
37
-9
.9
0.
36
-9
.9
0.
39
-9
.9
18
:Q
5B
0.
50
-9
.9
0.
52
-9
.9
0.
52
-9
.9
0.
54
-9
.9
0.
53
-9
.9
0.
55
-9
.9
19
:Q
5C
0.
34
-9
.9
0.
36
-9
.9
0.
37
-9
.9
0.
39
-9
.9
0.
38
-9
.9
0.
41
-9
.9
20
:Q
6
2.
16
9.9
2.
33
9.9
1.9
6
9.9
2.
15
9.9
1.9
1
9.9
2.
07
9.9
23
:Q
9A
1.0
4
2.
7
1.0
7
5.
3
1.0
2
1.7
1.0
5
3.
4
1.0
3
1.8
1.0
4
2.
2
24
:Q
9B
1.3
7
9.9
1.2
5
9.9
1.3
6
9.9
1.2
5
9.5
1.3
3
9.9
1.2
5
8.
3
25
:Q
9C
1.5
0
9.9
1.3
6
9.9
1.5
1
9.9
1.3
6
9.9
1.4
2
9.9
1.3
2
9.1
26
:Q
9D
1.1
5
9.3
1.2
3
9.9
1.1
6
8.
7
1.2
6
9.9
1.1
3
6.
2
1.2
0
8.
8
27
:Q
9E
1.1
1
7.9
1.1
1
8.
0
1.0
8
5.
1
1.0
8
4.
8
1.1
0
5.
2
1.0
9
4.
4
28
:Q
9F
0.
97
-1
.6
0.
94
-3
.2
0.
95
-2
.2
0.
91
-4
.2
0.
91
-3
.5
0.
89
-4
.4
29
:Q
9G
0.
87
-8
.1
0.
86
-8
.5
0.
84
-9
.2
0.
83
-9
.7
0.
85
-7
.3
0.
84
-7
.8
30
:Q
9H
1.1
2
5.
6
1.1
6
7.3
1.1
3
5.
8
1.2
2
9.3
1.0
9
3.
6
1.1
5
5.
3
31
:Q
9I
0.
76
-9
.9
0.
77
-9
.9
0.
76
-9
.9
0.
77
-9
.9
0.
76
-9
.9
0.
78
-9
.9
32
:Q
10
0.
86
-9
.9
0.
91
-6
.9
0.
90
-6
.3
0.
94
-3
.9
0.
96
-2
.4
1.0
0
0.
2
No
tes
.M
N
SQ
=
m
ea
n
sq
ua
re
re
sid
ua
lfi
ts
ta
tis
tic
;Z
ST
D
:s
ta
nd
ar
di
ze
d
m
ea
n
sq
ua
re
re
sid
ua
lfi
ts
ta
tis
tic
;v
al
ue
si
n
ita
lic
fo
rI
nfi
to
rO
ut
fit
M
nS
q
>
1.3
4;
va
lu
es
un
de
rli
ne
d
fo
rI
nfi
to
rO
ut
fit
M
nS
q
<
0.
64
.
BioMed Research International 23
Ta
bl
e
15
:S
F-
36
m
en
ta
lh
ea
lth
sc
al
eR
as
ch
an
al
ys
is
su
m
m
ar
y
Ite
m
an
d
Pe
rs
on
In
fit
an
d
O
ut
fit
sta
tis
tic
sf
or
six
w
av
es
of
da
ta
co
lle
ct
io
n.
W
av
e1
W
av
e2
W
av
e3
W
av
e4
W
av
e5
W
av
e6
Pe
rs
on
s
M
EA
N
-.0
8
-.0
4
-.0
2
-.0
3
-.0
6
-.0
6
S.
D
.
.3
0
.2
8
.31
.3
0
.2
9
.3
0
M
A
X
.3
0
1.6
4
1.3
8
.3
0
.2
9
.3
0
M
IN
1.8
7
-3
.5
4
-2
.9
9
2.
37
2.
16
2.
12
In
fit
-M
N
SQ
1.0
1
1.0
1
1.0
2
1.0
2
1.0
2
1.0
2
In
fit
-Z
ST
D
-.3
0
-.4
0
-.3
0
-.3
0
-.3
0
-.2
0
O
ut
fit
-M
N
SQ
1.0
6
1.0
8
1.0
6
1.0
3
1.0
2
1.0
1
O
ut
fit
-Z
ST
D
-.2
0
-.2
0
-.2
0
-.2
0
-.2
0
-.2
0
Pe
rs
on
se
pa
ra
tio
n
.53
.33
.4
5
.3
6
.3
6
.4
1
Pe
rs
on
re
lia
bi
lit
y
.2
2
a
.10
a
.17
a
.11
a
.12
a
.14
a
Ite
m
s
M
EA
N
.0
0
.0
0
.0
0
.0
0
.0
0
.0
0
S.
D
.
1.1
7
1.2
0
1.1
9
1.1
3
1.3
1
1.0
7
M
A
X
1.5
9
1.7
8
1.7
5
1.7
5
2.
13
1.6
7
M
IN
-1
.8
8
-2
.0
4
-2
.0
8
-2
.0
4
-1
.9
4
-1
.9
5
In
fit
-M
N
SQ
1.0
2
1.0
5
1.0
2
1.0
0
.9
9
.9
8
In
fit
-Z
ST
D
.10
.2
0
-.6
0
-.3
0
-.5
0
-.5
0
O
ut
fit
-M
N
SQ
1.0
5
1.0
7
1.0
4
1.0
2
1.0
1
1.0
0
O
ut
fit
-Z
ST
D
.10
.8
0
.2
0
.10
-.1
0
-.3
0
Ite
m
se
pa
ra
tio
n
95
.7
7
89
.12
83
.9
8
77
.8
5
68
.8
9
59
.3
8
Ite
m
re
lia
bi
lit
y
1.0
0
1.0
0
1.0
0
1.0
0
1.0
0
1.0
0
No
tes
.a
Pe
rs
on
or
ite
m
re
lia
bi
lit
y
<
0.
8;
b I
te
m
se
pa
ra
tio
n
<
3.
0;
c P
er
so
n
se
pa
ra
tio
n
<
2.
0;
va
lu
es
in
ita
lic
fo
rI
nfi
to
rO
ut
fit
M
nS
q
>
1.3
4;
va
lu
es
un
de
rli
ne
d
fo
rI
nfi
to
rO
ut
fit
M
nS
q
<
0.
64
.
24 BioMed Research International
an Infit MNSQ statistic that was less than 0.70: RE01:Q5A,
RE02:Q5B, and RE03:Q5C. Item SF01:Q6 had an Infit MNSQ
statistic that was greater than 1.30.
When the item residuals from the RMMoutput were fac-
tor analysed, no significant factor loadings were present (see
Table 16).This indicated that the unidimensional requirement
of the SF-36 total scale was met. The raw variance explained
by the SF-36 mental health scale over the six waves of data
collection ranged from 62.5% to 66.1% and the unexplained
variance in the first contrast ranged from 15.1% to 16.5%.
An inspection of the PTMEAs for the SF-36mental health
scale indicated that, for all other items, the PTMEA correla-
tions had acceptable values. All the SF-36 mental health scale
items had PTMEAs that were positive, supporting item-level
polarity.
The functioning of the six rating scale categories was
examined for the SF-36 mental health scale. Items which are
easier are located at the bottom of the SF-36 mental health
person-item map while more difficult items are located at
the top of the map. The patterns of more challenging items
and less difficult items on the person-item map for each of
the six waves of data collection appear to be fairly consistent.
The category logit measures ranged from -3.86 to 2.57 (see
Table 17). Of the six rating scale categories, only one had infit
MNSQ scores that fell outside the 0.7-1.30 range and/or a z-
score that fell inside the +2 to -2 range over the six waves
of data collection, this being category one. The infit MNSQ
scores for this rating category ranged from 1.38 to 1.41 (see
Table 17). The results indicated that the six-level rating scale
used in the SF-36 mental health scale might not be the most
robust to use (see Supplemental Figure 6), however, the full
range of ratings were used by the participants who completed
the SF-36 mental health scale. The probability curves for the
rating scales of the six waves of data collection illustrated that
each threshold estimate represented a separate point on the
measure variable and the latter five response categories were
the most probable category for some part of the continuum.
Rating category one was problematic.
The Rasch output logit performance scores for the par-
ticipants were compared to determine if any of the SF-36
mental scale items exhibited differential item functioning
(DIF), based on marital status and area of residence (urban
versus regional) (see Table 18). Six of the SF-36 mental health
items exhibited a consistent pattern of DIF over the six waves
of data collection. Items SF01:Q6, MH01:Q9B, MH02:Q9C,
MH03:Q9D, MH04:Q9F, and MH05:Q9H exhibited DIF
based on both marital status and area of residence (see
Table 18). It should be noted that items MH01:Q9B and
MH03:Q9D had infit MNSQ statistics that fell outside the
0.7-1.30 range. SF-36 physical health items MH01:Q9B and
MH03:Q9D appear to be particularly problematic items
based on the RMM analysis findings.
4. Discussion
4.1. IsThere Disordering or Dysfunction within the SF-36 Items
against theConstruct BeingMeasured? For the SF-36 as a total
measure, the rating scale categories increased monotonically,
indicating that rating response scales were being used as
expected and are appropriate for measurement across all
waves. Previous longitudinal evaluation of the measure using
CCT methods found poor test-retest reliability between two
timepoints twoweeks apart [36]. Previous research using IRT
methods have been largely cross-sectional, providing little
longitudinal evaluation of the measure using this method
[5, 6, 10, 17]. In this sample, the pattern of more and less
difficult items is consistent, indicating that item difficultly
remained stable across each wave. Despite consistency across
time in this sample, redundancy emerged as an issue with
several total scale items displaying the same level of difficulty
across all waves of data. This was seen again in both the SF-
36 mental and physical health summary scores. It appears
redundant items span across all uses of the measure and this
suggests that item descriptors need to be more specific to
avoid overlap across similar items.
Category Six of the SF-36 physical health summary scale
and Category One of the SF-36 mental health scale had
scores outside the acceptable range, which may indicate
these rating categories are not robust for use in longitudinal
studies. Disordered categories had been seen in a previous
evaluation of the SF-36, with authors suggesting collapsing
some category response options [5]. These findings support
this issue with the SF-36. Further investigation into the
category disordering in the SF-36 mental and physical health
response scale is warranted and collapsing of the response
option categories may improve this, as suggested in previous
literature [5, 17].
When examining summary statistics for total SF-36
items, the mean person reliability fell in the unacceptable
range. Inadequate person separation reliability was also seen
across all waves of data, in both summary scales. The person
separation index indicates the instrument used as a whole
and as summary scales is not sensitive enough to separate
high and low performances in the sample [29]. This presents
an issue with internal consistency across all presentations
of the measure. Comparatively, using classical methods, the
measure was seen to discriminate between patients pre-
and postoperation [37]. Results using IRT suggest that the
measure is unable to discriminate between high and low
performances.
While results of IRT have raised doubts of the measures
internal consistency, results from classical testing methods
report strong internal consistency, reflected in high Cron-
bach’s alpha scores. When validating the measure in patients
with endometriosis, Cronbach’s alpha for the total scale was
above acceptable cut-offs [38]. Internal consistency scores
have also been seen to be above .9 for the full scale and above
.7 for each subscale [39]. In addition to internal consistency,
the measure displayed acceptable content validity, correlating
strongly with similar measures [38]. IRT assesses instrument
reliability at item level, rather than instrument-level as
well as considering considers the importance of participant
responses.
The contrast between results from IRT and CTT could be
due to the further focus at item level that is characteristics
to IRT. It is possible that overlapping items identified in the
person-item map are contributing to lack of sensitivity in
the scale. Addition of more items or altering current items
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to improve sensitivity may improve the person reliability.
Further investigation into the similarity and specificity of
these items is warranted, to ensure items capture the full
variable being measured.
4.2. Do the SF-36 Items Have a Consistent Hierarchy and Good
Distribution across AllWaves? Several items on the total scale
and both summary scales were found to have Infit statistics
outside of the acceptable range. Many of the items remained
problematic regardless of investigated as wholemeasure or by
summary scale. The number of misfitting items was slightly
lower when used in summary scales; however this can be
due to the less items included in the summary scale analysis.
These underfitting items create concerns about degradation
of the model and the validity of the measure as a measure
of health related quality of life [15]. Further investigation
into such items is required to determine the reason for
underfit. While overfit items do not degrade the model,
they can result in misinterpretation of the model as working
better than expected and also warrant further investigation
[15].
4.3. Does the SF-36 Measure One or More Constructs? The
measure proved to be unidimensional across total scale and
summary score analyses, indicating responses to each scale
are likely to be determined by a single trait. As a total scale,
the first single factor accounted for close to 60% across all
six waves and the factor was considered unidimensional [32].
Residual analysis also indicated no second dimension or
factor existed, further confirming unidimensioanlity of the
total scale [33]. Analysis of all eight subscales revealed each
scale measured a single latent trait [6]. Principal components
analysis of the physical and mental health summary scores
has confirmed the presence of a two-factor model, further
corroborated by the results of the current study support the
mental and physical health scales [12].
Results suggest the responses to measure are determined
by a single factor. While the responses may be determined by
a single factor, previously identified misfitting and overlap-
ping items may degrade the model and validity, suggesting
that it may not be health-related quality of life that is deter-
mining response to these items. Further research should aim
to correct misfitting items and reassess unidimensionality.
4.4.Were All Items in the SF-36 Instrument Used by All Groups
in the Same Way? It appears that marital status and area
of residence influence responses to both total and summary
scale items. Differential item functioning has identified in
the SF-36 previously, with health issues such as hypertension,
respiratory issues, and diabetes influencing responses on five
items in the measure [10]. Previously, the presence of DIF
has been considered negligible, as it was only present for a
small number of items [10]. As the SF-36 is a health-related
quality of life measure, it is plausible that marital status or
area of residence would have an impact in this domain as
these factors can influence healthcare use and quality of life.
However, the presence of DIF limits the ability of scores to be
comparable across different populations.
While several items on each summary scale and total
scale exhibited DIF, only item 24:Q9B demonstrated DIF
across analysis of total scale and items in the summary scales.
This particular item also demonstrated Infit statistics outside
the acceptable range, proving to be particularly problematic
in every presentation of the measure. Several other items
demonstrated DIF and misfit. Given that the number of
items exhibiting DIF andmisfit across all presentations of the
measure, further investigation is needed into these specific
items.
4.5. Limitations and Future Research. While the current study
revealed differences between IRT and CTT evaluations of
the SF-36, it did not compare each method in the same
sample. Future research may perform both methods using
the same sample, in order to explain the differences between
methods and advantages of applying different frameworks
when developing and evaluating measures. It may also be
beneficial to compare methods longitudinally. A further
limitation is the rate of attrition in the sample. While attrition
is to be expected in a longitudinal study, results between
waves should be interpreted in light of this.
The results suggest the SF-36 is not as sound as previously
suggested. It can be delivered as eight subscales and future
research may apply the RMM to each subscale to evaluate
the efficacy of the measure in this form. Based on the RMM
findings in the current study, future research should further
evaluate this measure using IRT methods. Results suggest
multiple items needed to be reassessed to avoid degrading
themodel and improve performance of the SF-36 as a reliable
measure of health-related quality of life.
5. Conclusions
Previous evaluations of the SF-36 have relied on cross-
sectional data; however, the findings of the current study
demonstrate the longitudinal efficacy of the measure. While
using of the measure remained consistent across time for
both the whole measure and summary scales, several issues
were identified. Previous studies evaluating the SF-36 using
CCT methods describe the measure as reliable and valid.
However, evaluating the measure by application of the RMM
indicated issues with internal consistency, generalisability,
and sensitivity when the measure was evaluated as a whole
and as both physical and mental health summary scales.
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